Respiratory tracker: eHCPs in the UK were quick to respond to news about high number of pneumonia cases in China

21.12.2023 | Tracker

Respiratory tracker: eHCPs in the UK were quick to respond to news about high number of pneumonia cases in China

​​Between 21 November and 20 December 2023 CREATION Pinpoint® tracked the conversations of UK eHCPs discussing respiratory diseases on X (formerly Twitter). We analysed 3,269 posts by 1,245 eHCPs.

There was a flurry of eHCP activity on November 22 and November 23, as healthcare professionals reacted to reports from the World Health Organisation of cases of “undiagnosed pneumonia” in China. eHCPs were quick to draw comparisons to the start of the COVID-19 pandemic, with many stating that the news should be taken more seriously than it had been at the end of 2019.

Throughout 22 to 24 November, a large number of eHCPs interacted with content around the British Thoracic Society’s Winter Meeting 2023. Asthma was the most spoken about respiratory illness at the BTS Winter meeting. In particular, eHCPs discussed the “global catastrophe” of preventable asthma deaths worldwide. Some eHCPs, such as cardiorespiratory consultant Laura Graham shared content which spoke about the effect of the “cost of living crisis” on respiratory illness in the UK.

A post from Iain Beardsell, a consultant at University Hospital Southampton, made on December 6 was one of the most widely shared posts from the study period, being shared by 28 other eHCPs in the UK. The post, which addressed the “myth” that hypoxic drive is the cause of rising CO2 in COPD, engendered a lively discussion amongst eHCPs. While some eHCPs agreed wholeheartedly, such as Mark Forrest who welcomed “common sense at last” about the myth, other eHCPs felt that the myth still had some value as “a cautionary tale”.  

Each month, we track the eHCP conversation relating to respiratory disease. You can read other editions in the Respiratory Tracker archive .

You can also keep up to date with other pharmaceutical tracking updates, including how HCPs engage with Top 50 pharma and which product approvals are catching their attention.  To receive these updates straight to your inbox you can sign up to receive our monthly eJournal with all of our latest HCP insights. 

If you would like to dig deeper into what we have seen this month then please do get in touch

Methodology

  • This article analysed the conversation on 1,245 of HCPs in the UK discussing respiratory disease and related terms between 21 November and 20 December 2023 using CREATION Pinpoint®.
  • Between 21 November and 20 December 2023, there were 3,269 UK eHCP mentions of respiratory disease and related terms, from 1,245 unique UK eHCP authors. 

Share this article

Meet the Author

Cameron Bassindale

Cameron’s academic background in Social Sciences is helping to inform his development of world-class insights, led by weaving stories to help shape and inform actions taken by key stakeholders in the Pharmaceutical industry.

When he’s not watching his beloved Arsenal FC, Cameron can usually be found with his nose in a book or out for dinner with friends.

Suggested next


UK HCPs highlight areas for change after asthma death toll data

21.05.2021 | Article

UK HCPs discuss inhaler technique on World Asthma Day

HCPs used social media to spread the latest articles and scientific findings surrounding...

By Mark Sullivan

22.01.2023 | Article

Respiratory tracker: eHCPs focus on paediatric cases

An increased attention towards RSV by HCPs was noticed by CREATION in the last month

By Mark Sullivan

View all articles >